As part of Jazz’s commitment to putting patients first, we are providing plain language summaries for certain clinical trials below. These plain language summaries provide clinical trial results in an easy-to-understand format so all patients can obtain more information on the study results.
|A Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy
|A Long-Term Safety and Maintenance of Efficacy Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or Obstructive Sleep Apnea
|CREST UK: CPX-351 Real-World Effectiveness and Safety Study
Disclaimer: The purpose of plain language summaries is to provide clinical trial results in an easy-to-understand format. Plain language summaries are not intended for any promotional purposes or as a replacement or substitute for medical advice provided by your doctor or healthcare provider. It is important for you to discuss your treatment options, and any questions that you may have, with your doctor or healthcare provider. You should not use this website to diagnose or treat a health problem or disease.
This page is for U.S. residents only. By clicking on this page, you confirm you are a U.S. resident.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.